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Abstract
Therapeutic proteins are used to successfully treat hemophilia, Crohn’s Disease,
diabetes, and cancer. Recent product recalls have occurred because of sub-visible particle

formation resulting from the inherent instability of proteins. It has been suggested that
particle formation is associated with late stage processing steps of filling, shipping, and
delivery. Previous work at the University of Denver demonstrated that fluid cavitation
can generate a large number of sub-visible protein particles in ultra clean formulations,
but that mitigation can be achieved with fluid property manipulation. The goal of this
research was to (1) assess the risk of cavitation under common pharmaceutical
manufacturing conditions (i.e., pipe contraction and pumps), (2) establish a simple
threshold criterion, and (3) suggest a series of mitigation techniques based on these
thresholds. To accomplish these tasks, computational fluid dynamic simulations for a
variety of pipe contraction and vial drop conditions were performed. The impact of
geometry, fluid properties and operating conditions were varied to establish thresholds
and mitigation strategies. The results of this research show that reducing the turbulence in
a fluid system will cause the fluid to be less likely to cavitate. Additionally, threshold
bounds were created that establish a definitive transition at which cavitation will occur.
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1. Chapter One: Motivation
Introduction
Therapeutic proteins are used to treat hemophilia, Crohn’s Disease, diabetes, and
cancer [1]. These proteins are inherently unstable which can cause them to denature and

aggregate [1–5]. If the patient is to receive the designed effect of the therapeutic protein,
the protein must be delivered in the design structure and shape, known as the native state.
Studies have shown that there can be adverse effects if proteins are not in their native
state. These adverse effects can include reduction in responsiveness to the drug therapy
eventually leading to immunogenicity [3–5]. Studies have also shown that therapeutic
proteins are highly susceptible to degradation because of their weak bonding structures
[2]. The use of therapeutic proteins is on the rise as they are becoming more affordable
and the availability of drugs has increased in recent years [2]. Additionally,
pharmaceutical companies are increasing the scale of productions resulting in filling vials
and syringes in a rapid manner. This increase in the rate of production results in larger
equipment being utilized, which leads to increased instability in the proteins [6].
Mass Production of Therapeutic Proteins
In order to bring a therapeutic protein to the market, companies spend years and
extensive resources to create and cultivate exact strands of proteins [7]. When making
these new proteins, companies begin with small scale equipment to grow and cultivate
1

the new proteins leading to animal testing, human testing, and eventually FDA approval
for human use. In this process, the company is not worried about the quantity of
therapeutic protein produced rather the quality of the end product used to gain FDA
approval. Once a drug is approved for use in humans and available on the market,
companies increase production where the goal is to produce more drugs more efficiently.
To do this, the pharmaceutical solution is pumped at higher speeds and pressures to
increase the efficiency of the manufacturing process. Additionally, the piping, pumping,
and associated valve equipment used to transport the solution is altered because of the
new specifications for larger sizes, higher flow rates, and pressures. The significant of the
changes in fluid and flow properties when machinery is changed from small to large scale
is not evaluated, therefore the retrofitted system has a high potential to cavitate.
Cavitation
Cavitation is a widely recognized and usually undesired phenomenon where a
liquid flash boils to vapor and then collapses. Flash boiling in these cases occurs locally
due to hydrodynamic, mechanical, or acoustic forces that lower the local pressure to
below the critical vapor pressure. This critical pressure is not well correlated to the vapor
pressure of the pure liquid and has some dependence on impurities, intensity, and time
scale of the applied force. Because this is a local phenomenon once the external force
driving the low pressure is removed; pressure returns rapidly to the bulk value and the
vapor bubble rapidly collapses. During the collapse of the vapor bubble to the bulk fluid,
high velocities are present and collide at a singularity point creating high pressures and
large amounts of localized heat. The subsequent dissociation of water can occur, which
2

generates free radicals. These are localized phenomenon making the temperature and
pressure gradient extremely high at the site of cavitation. Although the primary key to
understanding when cavitation occurring is well defined the factors that reduce its onset
and likelihood are not widely documented.
Cavitation is an undesired phenomenon in many systems (boat propellers, pumps,
and piping systems) because the vapor bubbles change the flow characteristics to be
turbulent and unsteady. Both of these effects can cause massive vibrations and noise in
machinery leading to large reductions in performance and efficiency [8]. In addition to
reduced performance, the high pressures resulting from the bubble collapse can cause
surface pitting and erosion to all but the toughest metals. However, it is desired in
applications such as nebulizers to produce aerosol droplets for drug delivery systems via
inhalation. Although there has been little documentation that directly links cavitation to
therapeutic protein denaturing, the violent nature of cavitation leads one to understand a
possible connection [5,9].
Locations of Cavitation
Although the factors that reduce the onset of cavitation are not readily understood,
areas where cavitation is likely to occur are well known. In piping systems, sharp corners,
pipe constrictions, pumps, and valves are locations where cavitation can and does occur.
This is due to the large increase in velocity in these locations. By means of Bernoulli’s
equation, an increase in velocity requires a decrease in pressure. Therefore, in these
systems where the localized velocity increases greatly, the pressure decreases creating a
higher likelihood of cavitation. In piping system, Figure 1.1, utilizing an incompressible
3

fluid, the mass flow rate must remain constant and is a function of cross sectional area of
the flow and fluid velocity. As the cross-section of the fluid decreases, the velocity of the
fluid must increase to conserve the mass flow rate. This is magnified when the flow
separates and creates pockets of recirculation reducing the cross-sectional area of the
fluid forcing the fluid to a higher velocity. Sharp corners are problematic because as a
fluid passes around a corner it is likely to separate resulting in recirculation, reduction in
cross sectional area, and an increase in velocity, ultimately leading to a decrease in
pressure. Pumps are problematic because it has sharp edges and fast moving parts. If
these parts move fast enough a vacuum or low pressure region is created on the face of
the moving part. Valves are problematic because if it is closed quickly without stopping
the pumps forcing the flow, a high pressure wave can form on the upstream side of the
valve and a low pressure wave can form on the bottom side of the valve. Additionally, as
the valve closes, it acts like a constricting channel and if left partially open is a
constricting channel where cavitation is likely to occur, Figure 1.1.

4

Figure 1.1 – Problem areas where cavitation is likely to occur in pipe constrictions
(top left), pipe turns (top right), closed valves (bottom left) and partially closed
valves (bottom right).
Cavitation Modeling
Due to the complexity of cavitation and the different ways this phenomenon can
occur, modeling cavitation is challenging. Not only does modeling cavitation require a
detailed understanding of when a flow cavitates to form a vapor bubble, it also requires
understanding when a vapor bubble will collapse back into the bulk fluid. For specific
applications custom codes can be created that apply for a specific case, but a generic code
that applies across all applications of cavitation is much more challenging. The available
codes for specific application include cavitation due to hydrofoils, shock waves,
5

turbulence, and high speed propellers [9–16]. These models are only valid for their
specific application. Singhal et. al. has produced several specific model, similar to the
ones previously mentioned, and has produced “the Full Cavitation Model” utilizing a
robust algorithm with generic cavitation application [8]. The Full Cavitation Model is
currently being utilized by industry and commercially available Computational Fluid
Dynamics (CFD) software to model water and oil pumps, inducers, impellers, and fuel
injection systems [8]. Although this model is being used in industry with promising
results, there are still limitations to this model, mainly in the method of when a bubble
collapsing back into the bulk fluid. Research at the University of Denver has utilized the
Full Cavitation Model with success. For this research, CFD modeling will be utilized, but
without a cavitation model. The goal of this research is to understand the leading factors
of cavitation in an attempt to avoid the bubble collapsing back into the bulk fluid. For this
reason we are only investigating the flow before cavitation and are not interested in the
fluid flow after cavitation has occurred. This will also remove any discrepancies with
modeling cavitation and focus on the lead up to cavitation.
Proteins Denaturation
The ionic and covalent bonds holding the molecules in the protein together are
very strong, but the secondary bonds holding the shape and structure of the protein are
relatively weak compared to ionic and covalent bonds. These secondary bonds can be
broken by either chemical or physical instabilities [2]. Physical instabilities include
denaturation, aggregation, precipitation, and absorption [2]. When these unique bond
structures and shapes of therapeutic protein are broken, the proteins become partially or
6

fully unfolded. These unfolded proteins can group together to form large aggregates.
These larger aggregates are regulated by the FDA and are blamed for the adverse effects
seen in patients [3–5]. Recent studies have shown that smaller aggregates, in comparison
to previous research, still have the potential to cause adverse effect in patients [17].
Several factors can lead to protein unfolding and aggregation such as amino acid
sequence, pH level, temperature, and concentration [17]. Additionally, these proteins
have highly hydrophobic and hydrophilic parts. Because of this, when the protein comes
in contact with a gas liquid interface, it is pushed and pulled to the point where they can
change shape and unfold. In terms of protein stability, cavitation results in at least two
events that are undesired. The large temperature gradients and additional gas liquid
interfaces produced by cavitation are undesirable because of their potential to cause
protein degradation. The focus of this research will be on physical instabilities causing
protein degradation.
Past Work
The research involving protein stability was first documented by Hsien We in
1931, but the application of proteins to patients for therapeutic effects is still considered a
new treatment [18]. Our previous research has demonstrated and measured the
degradation of proteins under shipping and administering conditions.
Cavitation in Ultrasonic Nebulizer
Previous work using an ultrasonic nebulizer to vaporize IVIg proteins
demonstrated three important findings: (i) cavitation causes protein degradation, (ii)
proteins are the sites for nucleation, and (iii) viscosity plays an important role in the rate
7

of cavitation [5]. Using a Mabis Mist II Handheld Ultrasonic Nebulizer, IVIg proteins
were used to evaluate the effects of the gas-liquid interfaces, energy per mass, time
effects, and protein concentrations. If the protein is the site of nucleation, the higher the
protein concentration in the solution the higher likelihood of cavitation. Although the
importance of viscosity was noted in this research, no attempt was made to correlate or
explain this phenomenon.
Cavitation in Shipping Collisions
Previous work demonstrated if a therapeutic protein is dropped in the shipping
process or by a patient when administering the drug, cavitation occurs [17]. The work
demonstrated cavitation occurs and proteins are destroyed when subject to a standard
shipping impact. Using a high speed microscope images were taken at a rate of 6000
frames per second of a 3 mL vial filled with 1 mL of 1mg/mL anti-streptavidin dropped
using a Lansmont Shock Tower. The vials were dropped from 10, 20, 30 and 40 inches.
The shock tower allowed an unobstructed free-fall and controlled collision. In the high
speed images, it is clear cavitation occurs due to the visible bubble formed and then the
immediate collapse, Figure 1.2.

Figure 1.2 – High-speed video frame shots from Lansmont mechanical shock tower.
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After the solution was dropped and undergoes an impact, gelatinous particles
adhered to the sides of the vials. A BradFord assay was used to quantify the amount of
adhered protein. The height of the free-fall is positivily correlated with the amount of
protein aggregation, Figure 1.3. This research showed that when a vial of therapeutic
proteins undergo an impact it cavitates, aggregates, make it no longer in a usable state for
therapeutic benefit. Additionally, the oxidation occurred because free radicals were
formed in the solution and free radicals are a direct result of cavitation.
14
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Figure 1.3 – Amount of anti-streptavidin mAb adhering on vial walls of samples
after application of mechanical shock in the Lansmont 15D mechanical shock tower
as a function of drop height. The mass of adherent mAb was measured by the
Bradford assay [17].
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Objectives
The present project is a continuation of previous effort in order to assess the
relative risk in terms of the probability for cavitation to be present in a broader variety of
pharmaceutically relevant processing and delivery steps. Three specific objectives of the
work are to: (i) assess the likelihood of cavitation in other more common processing
equipment in terms of non-dimensional fluid parameters, (ii) determine why viscosity
appears to dominate cavitating system mitigation, and (ii) explore mitigation strategies
for the most violent of cavitating scenarios – that of a vial drop. CFD modeling will be
utilized to evaluate the influence of fluid, flow, and geometric parameters on the onset of
cavitation. Classical non-dimensional fluid numbers will be evaluated and plotted to
characterize the flow patterns in order to understand when cavitation is likely to occur,
which should shed light on the dominance of viscosity in mitigating cavitation. The high
energy case of vial impact examined via fluid-solid interaction modeling to develop
energy dissipation methods that are both cost effective and easy to implement. Finally,
the conclusions made through this research will be applied in a more generic way to the
manufacturing and delivery devices as recommendations for mitigation strategies.
Outline
This Thesis will characterize hydrodynamic cavitation and mechanical shock
cavitation by means of CFD and Fluid Solid Interaction modeling and determine
mitigation techniques to be implemented by pharmaceutical manufacturing companies.
Chapter 2 will examine hydrodynamic cavitation by means of a constricting channel
where CFD modeling is used to evaluate the likelihood of cavitation. Chapter 3 will
10

examine cavitation due to mechanical shock by means of a high energy impact between a
vial and a surface. This analysis will utilize CFD modeling to determine the likelihood of
cavitation. Chapter 4 will examine cavitation under the same high energy impact, but FSI
modeling will be utilized to couple the fluid and solid models together. Chapter 5 will
summarize the results, provide recommendations for pharmaceutical manufacturing
companies to mitigate cavitation, and outline future work.

11

2. Chapter Two: When Does Cavitation Occur?
Background
Conventional pharmaceutical processes use automated machines to fill vials and
syringes for self-administering and administering by a trained professional. The
manufacturing and filling process is done on a large scale production machinery where
the vial or syringe is filled as fast as possible. To accomplish the high speed filling, the
solution is pumped at high pressures in small tubing with pipe constrictions and abrupt
turns. Valves are opened and closed quickly creating high pressure waves on the
upstream side of the valves and a low pressure wave on the bottom side of the valves. All
of these processes add energy to the fluid which can potentially lead to cavitation. As
previously discussed, cavitation destroys the native state of the therapeutic protein
dissolved in the aqueous solution and has the potential to render the protein unsafe for
human administration.
The objective of this research is to assess the risk of cavitation in
pharmaceutically relevant conditions and identify some risk mitigation techniques. To
accomplish this, Computation Fluid Dynamics (CFD) modeling will be used to model the
flow of an aqueous solution over a vast number of operating conditions. The simulation
results will be analyzed to identify processes with a high likelihood of cavitating events
and propose simple solutions based on driving parameters.
12

Cavitation is the local phase transformation of a liquid to a vapor phase due to a
local low pressure region. In flow induced cavitation, also known as hydrodynamic
cavitation, fluid, flow, and geometric parameters influence low pressure regions. For
example, Bernoulli’s equation, Equation 1, demonstrates that pressure strongly links to
local velocity, while the conservation of mass expresses the strong influence of the inlet
to outlet area (e.g., diameter ratio for pipes) on local velocity. The influence of
constriction edge type on flow behavior as seen through alteration of the minor head loss
is less intuitive, Table 2.1. Large values for the head loss term can impose two separate
influences on the flow. First, large head losses scavenge flow energy or pressure drop
from accelerating velocity. Second, the method by which the energy scavenging occurs is
through high turbulence where the energy is used for rotational velocity rather than axial
velocity. In systems that comprise areas of high turbulence, the related shear stress is
extremely high. When modeling cavitation in these high turbulent areas, the traditional
transition point at vapor pressure does not accurately describe when a flow vaporizes and
condenses. The critical pressure of the fluid does accurately describe the point of phase
changes between liquid and vapor for a turbulent flow [19]. The critical pressure is a
function of the strain-rate and the turbulent energy, Equation 5.
constant

1
2

2

(1)

Classically, the relative importance of geometry, fluid properties, and flow
conditions on hydrodynamic phenomena is not conducted via dimensional quantities.
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Instead non-dimensional terms are created to enable the transfer of the information to a
broad range of applications as desired in this case.
Table 2.1 – Minor loss coefficient with different entrance types [20,21].

Dimensionless Numbers
Diameter Ratio
Diameter ratio can be used to characterize the geometric configuration of a
contracting or expanding flow. It is typically defined as a ratio of minor diameter to
major diameter, Equation 2, where Dr is the diameter ratio, Dminor is the minor diameter at
outlet, and Dmajor is the major diameter at the inlet.

(2)
14

Reynolds Number
The Reynolds number is the most readily used non-dimensional number in fluid
dynamics. It provides the relative ratio of inertial to viscous effects. Although frequently
used to monitor the transition from laminar to turbulent flow, it also provides a tool for
non-dimensionally describing the dynamic or velocity effects. In Equation 3, ρ is the
density of the solutions, v is the mean velocity of the fluid, L is the characteristic length,
and μ is the dynamic viscosity of the fluid.
ρ D

(3)
Vapor Pressure
A non-dimensional pressure term can be represented by numerous methods, most
of which need information about the vapor and critical pressure to the working fluid. The
vapor pressure is the pressure at which fluid changes phase from a liquid to a gas. It is
computed by the Clausius Clapeyron equation which is a function of the temperature of
the fluid, Equation 4 [20].
10

273.15

(4)
Where Pvap is the vapor pressure of the fluid, T is the temperature of the fluid, and
A, B, and C are experimentally determined constants provided by Poling et al. [20].
Critical Pressure
The critical pressure is the point when a fluid will cavitate after considering
turbulence. Several methods have been proposed to calculate the critical pressure [19].
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For this application and under these conditions, the most appropriate equation for the
critical pressure is derived by Singhal et al., Equation 5, because it used the turbulent
kinetic energy to account for turbulence in the model [8]. Where Pc is the critical pressure
and k is the turbulent kinetic energy. This results in a critical pressure equal to the vapor
pressure when turbulence is not present and an increase in the critical pressure when
turbulence is present.
0.195

(5)
Cavitation Number
Cavitation number is a dimensionless number used to characterize the likelihood
of a fluid to cavitate via a ratio of pressure difference between the local flow pressure and
vapor pressure of the fluid in relation to the dynamic pressure of the system. The
Cavitation number is independent of both the flow geometry and turbulence energy in the
flow, see Equation 6 [21], where Ca is the Cavitation number and Plocal is the absolute
pressure at a point in the fluid.
1
2

2

(6)
Pressure Recovery Coefficient
As in all pipes there is a pressure drop along the flow direction of the pipe. This is
magnified by the addition of a constriction. The pressure recovery coefficient, Cp,
quantifies this pressure loss which is determined by Equation 7, normalized by the
dynamic pressure [21]. Pout is the pressure at the outlet and Pin is the pressure of the inlet.
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1
2

2

(7)

Energy Length Scale
None of the previous non-dimensional quantities explore the significance of the
maximum principal stress or turbulence on the potential for a flow to cavitate. As this can
lower the critical pressure by 2-fold, its importance should likely not be ignored. Thus, it
is important to quantify the Kolmogorov length scale and the energy dissipation rate by
developing associated dimensionless parameters.
The Kolmogorov length scale is a length that characterizes the smallest eddies in
a flow. Energy is dissipated in a fluid flow through the energy cascade of eddy
dissipation. In each eddy, there are two smaller eddies that transfer the energy to a
smaller and smaller length scale. The cascade continues until the Kolmogorov length
scale is reached which is indicated by no more smaller eddies and at which point the
energy is transferred into heat which is dissipated by the fluid. This energy dissipation
happens at all scales of fluid flow. The Kolmogorov length scale is determined by the
viscous forces over energy dissipation per mass, Equation 8, where η is the Kolmogorov
length scale, γ is the kinematic viscosity, and ε is the energy dissipation rate.
3

1

4

(8)
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Energy Dissipation
The energy dissipation of the fluid was determined by the energy placed in the
system per unit mass. This was calculated using Equation 9 derived from Munson et al.
where ṁ is the mass flow rate, and m is the mass in the system [22].
(9)
Viscosity
Finally, the viscosity of pharmaceutical solutions changes exponentially as a function of
solution concentration due to chain entanglement [20]. Therefore, viscosity needs to be
represented accurately to provide information on how solution concentration can alter
hydrodynamic phenomena. Previous research conducted in the BioFluids Laboratory at
the University of Denver has measured the viscosity of the protein solution as a function
of solution concentration for IVIg protein. Using an exponential relation, the viscosity of
the solution can be determined by its protein concentration using Equation 10 [5]. Where
C1 and C2 are experimental constants and Ccon is the concentration of the solutions. The
range of concentrations for prefilled syringes and vials is large. For this reason, the range
of concentration will be defined from 0 to 25 mg/mL to ensure the entire spectrum of real
systems is covered.

1
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2∗

(10)

Methods
Model Description
To provide a controlled model that represents a range of pharmaceutical
manufacturing processes, with the potential to cavitate, a constricting square-edge
channel was created, see Figure 2.1. Parameters that should impact the probability of
cavitation in a flow are the fluid properties, the flow properties, and the geometric
properties which will be altered to span conditions found in syringe injection and rapid
vial filling. A pipe constriction is a good representation of a commonly occurring feature
where cavitation is likely to occur and this feature is present in piping systems, pumps,
and syringes. The fluid, flow, and geometric parameters altered were:
1. Major diameter (i.e., inlet)
2. Minor diameter (i.e., outlet)
3. Mass flow rate
4. Viscosity
5. Constriction edge type
6. Density
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Figure 2.1 – Geometric representation of axisymmetric model with constricting
channel with square-edge, 45 degree angle and fillet edge. The inlet height will vary
from 2 mm to 40 mm to account for different diameter ratios.
As previously discussed in Chapter 1, cavitation is a function of the localized low
pressure which is altered by fluid velocity, turbulence, and principal shear stress. These
factors can be affected by fluid properties like viscosity, geometric properties like area
constriction, and flow properties like flow rate and inlet turbulence. The diameter ratio
will be used to represent changes in the geometric area constriction and the mass flow
rate will be used to represent changes in the flow properties. The results from the
simulation will be analyzed using non-dimensional numbers to maximize the application
of the findings. The computational model proves to be more stable when a mass flow rate
is used to control the inlet of the model, rather than a velocity or pressure inlet. For this
reason, the density will remain constant, so the mass flow rate is the only factor effecting
the flow and velocity of the fluid. The density will be set to a value equivalent to that of
an aqueous solution.
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Fluid Model
To generate the CFD model ANSYS Fluent™ version 13.0.0 was used. This is a
commercially available fluid and thermal software with robust features for turbulence
modeling and phase change. To generate the geometric shapes and mesh for each model
Gambit® 2.4.6 was used as the preprocessor. Both of these software packages are
capable of being run through text commands and are executed through the DOS prompt,
allowing the models in each to be manipulated and controlled through a master Matlab
code.
The constricting channels were modeled using a 2D axisymmetric algorithm on a
HP Z800 Workstation using up to 7 processors. The models ranged in size from 6,000 to
10,000 cells with a max cell skewness of 0.36. The model was run in a steady-state
format and implemented with a pressure-based solver because the flow is subsonic and
incompressible. This solver utilizes the momentum equation (Equation 11), continuity
equation (Equation 12), and the energy equation (Equation 13). Where
vector,

is the derivative in 3 dimensional space, ̿ is the stress tensor,

is the velocity
is gravity, and

is external body forces. In the continuity equation Sm is a mass source term. In the
energy equation E is the total fluid energy, keff is the effective thermal conductivity of the
fluid, T is the temperature, h is the enthalpy, J is the diffusion flux, ̿

is the effective

stress tensor and Sh is a volumetric energy source. The standard k-ε turbulence model was
implemented with standard wall functions. This turbulence model was implemented
because it is specifically for modeling internal pipe flows similar to the case exhibited in
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this fluid model [23]. The fluid properties and flow characteristics were altered for each
model and were determined by the master Matlab code.
∙

∙

̿

(11)

∙

(12)

̿

∙

(13)
Matlab Code Setup
An evaluation of the entire design space utilized by automated pharmaceutical
filling machines was utilized to determine the overall risk of cavitation. The fluid
properties, flow characteristics, and geometric shape were altered in an systematic
manner so each variable could be analyzed independent of the others. Figure 2.2 is a flow
chart outlining the flow of the Fluent, Gambit, and Matlab codes. The journal files for
Gambit and Fluent were altered by Matlab to encompass the entire design space and the
resulting files were run in the command prompt. The Fluent analysis exported text files
with the desired outputs from the analysis and Matlab read the output variables,
calculated the desired values, and plotted them for analysis. Three different approaches
were used to explore the importance of different variables.
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Figure 2.2 – Analysis loop depicting the path by which the software packages pass
information to create different models with varying fluid, flow, and geometric
properties and then process the results.
Dimensionless Number Methods
The master Matlab code perturbed variables one at a time to create a matrix that
consisted of the following parameters in Table 2.2, resulting in 546 models and
corresponding data points that were plotted. The minor diameter was held constant and
the major diameter was swept from 5.714 to 40 mm to reflect a change in diameter ratio
from 0.7 to 0.1. This range was chosen because the 0.7 diameter ratio is representative of
a minor pipe constriction and 0.1 is representative of a constriction from a syringe to a
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needle. The mass flow rates were altered from 5 to 200 g/s which represents a slow flow
rate to a flow rate used to fill syringes and a fast flow rate used to fill vials [24]. The
viscosity ranged from 5.2 to 97.4 cP which represents a range of fluids from water to a
near gelatin solution. The density was not altered because it was directly related to the
mass flow rate. The inlet was modeled as a mass flow inlet, so altering the density would
directly alter the flow rate into the system. Therefore, changing the flow rate and density
would have the same effect on the system. The turbulence going into the model is
considered negligible with respect to the increase in turbulent energy due to the pipe
constriction.
Table 2.2 – Conditions at which the CFD models were evaluated resulting in 546
models that each produced one data point for the results section.
Major Diameter (mm)

5.7, 6.7, 8.0, 10.0, 13.3, 20, 40

Minor Diameter (mm)

4

Mass Flow Rate (g/s)

5, 8, 10, 20, 30, 40, 50, 60, 80, 100, 130, 160, 200

Viscosity (cP)
Density (kg/m3)

5.2, 9.3, 16.8, 30.2, 54.2, 97.4
1000

Edge Constriction Type
To determine if the type of edge has any impact the mouth of the constriction was
altered to a 45 degree angled wall and a fillet, Figure 2.1. The same 546 conditions were
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replicated for the 45 degree angle and the fillet channel and compared to determine what
effect the edge constriction type has on cavitation.
Geometric Scalability of Diameter
In each of the above models the minor diameter was held constant and the major
diameter was altered to account for the change in diameter ratio. In this section the
diameter ratio will remain constant at 0.5 and the major and minor diameter will be
altered to determine what effect they have on cavitation.
Results and Discussion
Dimensionless Numbers
The 546 different cases for the square-edge channel were evaluated resulting in
101 cavitating models. Figure 2.3 shows the diameter ratio as a function of the Reynolds
number and grouped into cavitating and non-cavitating conditions. The Reynolds number
was calculated at the exit of the minor diameter. Overlaid on the data are regions where
vial filling, syringe filling, and syringe discharge operations occur. Syringe and vial
filling operations exist in regions where a high number of cavitating cases exist. In the
syringe discharge operation there are no cavitating cases that fall directly inside of the
bounds of operation, but there are cavitating cases near the bounds. Figure 2.3
demonstrates cavitation occurs in pharmaceutical manufacturing operations and should
be addressed when designing new systems. However, Figure 2.3 does little to
characterize cavitation because the cavitating cases overlap the non-cavitating, cases
indicating a driving mechanism is not identified by the dimensionless quantities.
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Figure 2.3 – Diameter ratio as a function of the Reynolds Number with the data
separated by cavitating and non-cavitating conditions for the square-edge channel.
Overlaid on the data are general regions where vial filling, syringe filling, and
syringe discharge operations are likely to occur.
Figure 2.4 plots the lowest pressure observed as a function of the Reynolds
number with the data separated in cavitating and non-cavitating groups. This figure
shows that if the Reynolds number is below 500, cavitation is not likely to occur.
However, this figure does not resolve what will happen when the flow is above a
Reynolds number of 500 so it cannot be used to quantify when cavitation is likely to
occur.
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Figure 2.4 – Low pressure versus the Reynolds number for a constricting, squareedge channel using 546 Fluent models with data separated by cavitating and noncavitating groups.
The Cavitation number is a dimensionless quantity that describes how likely a
flow is to cavitate. Figure 2.5 plots the Cavitation number as a function of the Reynolds
number with the data separated into cavitating and non-cavitating groups. The velocity
term in the Cavitation number is used with respect to the outlet velocity in the minor
diameter. This figure shows that if the Cavitation number is below one, cavitation will
likely occur. This threshold value is not universal as cavitation is still observed at high
Reynolds numbers at Cavitation numbers as low as 0.1. The Cavitation number is
calculated using the local low pressure of the fluid. This local low pressure is determined
by a myriad of interconnected variables like fluid viscosity, fluid temperature, geometric
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configuration, turbulence levels, energy dissipation, flow characteristics, principal shear
stresses, and operating conditions. This makes the local low pressure a value that cannot
be computed by hand. Therefore, it must be experimentally determined or explored
through CFD modeling.
Alternatively, the equation for the pressure recovery coefficient, Equation 7, is
similar in nature to the Cavitation number, Equation 6, in that they both are a ratio of
pressure difference over dynamic pressure. However, the pressure difference in the
pressure recovery is determined by the inlet and outlet pressure not the local low
pressure. This makes the pressure recovery coefficient much easier to calculate relative to
the Cavitation number and this can be done without the aid of experimental measurement
or CFD analysis. Figure 2.6 plots the pressure recovery coefficient as a function of the
Reynolds number with a contour of diameter ratio. The velocity term in the pressure
recovery coefficient is used with respect to the outlet velocity in the minor diameter.
Although it is not a collapsed linear line, it does demonstrate that the diameter ratio is
reasonably captured by the Reynolds number and pressure recovery coefficient.
Therefore, little would be gained from a 3-D plot of the design space. Unlike the
Cavitation number, the pressure recovery coefficient, Figure 2.7 does not appear to
describe the potential for cavitation in a flow due to the strong overlap at Reynolds
numbers above 500.
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Figure 2.5 – Cavitation number versus the Reynolds number for a constricting,
square-edge channel using 546 Fluent models with data separated for cavitating and
non-cavitating groups.

29

Figure 2.6 – Pressure recovery coefficient versus the Reynolds number for a
constricting, square-edge channel using 546 Fluent models with contour colors of
diameter ratio.
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Figure 2.7 – Pressure recovery coefficient versus the Reynolds number for a
constricting, square-edge channel using 546 Fluent models with data separated into
cavitating and non-cavitating groups.
Edge Constriction Types
To this point, all of the data was for a square-edge constriction type. None of the
dimensionless quantities can capture the change in head loss and the resulting turbulence
associated with geometric configurations. Due to the nature of the edge types, the squareedge channel has the most turbulent energy and the fillet channel has the least. The same
546 conditions that were evaluated for the square-edge channel were also evaluated for
the 45 degree angle and the fillet channels. The mean low pressure increased from the
square-edge to the 45 degree angle channel and from the 45 degree channel to the fillet
channel. The mean values for the 3 edge constriction types is presented in Table 2.3 and
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the results from 3 identical conditions with varying edge constriction type are presented
in Figure 2.8. This increase in the mean low pressure is due to the turbulence added to the
system by the type of edge constriction, which also increases the critical pressure. As
more turbulence is added, the critical pressure increases. These changes in critical
pressure and low pressure result in a shift in the likelihood for cavitation. This is very
clear when considering the number of cases that did and did not cavitate. There was a
threefold decrease in the number of cavitating cases from the square-edge to the 45
degree angle, and another significant decrease from the 45 degree angle to the fillet
channel where no cases resulted in cavitation. This clearly demonstrates that changing the
type of constriction to a smoothed edge decreases the likelihood of cavitation.
Table 2.3 – Results from the square-edge, 45 degree angle, and fillet channels under
the 546 different conditions.
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Figure 2.8 – Comparison of critical pressure and low pressure for 3 models under
the same conditions except for different edge constriction types.
The effect of turbulence on cavitation can be captured in two methods: (1)
modification of the vapor pressure via substitution of the critical pressure or (2)
utilization of a non-dimensional flow parameter that captures turbulent strength better
than the Reynolds number. The Kolmogorov length scale represents energy dissipation
through viscous effects thus providing detailed information on turbulent strength or
intensity. Figure 2.9 shows the Kolmogorov length scale as a function of the Reynolds
number with a contour of diameter ratio for the three constriction edge types modeled. A
linear relationship between the logarithm of the Kolmogorov length scale and logarithm
of the Reynolds number indicates that the Reynolds number, diameter ratio, and
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turbulence behavior can be captured in the single robust quantity of the Kolmogorov
length scale. Returning to plot the Cavitation number as a function of the Kolmogorov
length scale, Figure 2.10 demonstrates that regardless of edge constriction type a
threshold value for Cavitation can be defined. Figure 2.11 plots the Cavitation number as
a function of Kolmogorov length scale with the threshold bounds for separating when
cavitation occurs. The threshold for non-cavitating bounds can be found by the following:
Non-cavitating if:
η < 8 μm

while

0.1

η > 8 μm

while

0.6

0.8617

1000

Square‐edge

Kolmogorov Length scale (μm)

45 degree
Fillet

100
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1
10
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Figure 2.9 – Kolmogorov length scale versus the Reynolds number for constricting
square-edge, 45 degree angle, and fillet channels under the same 546 conditions.
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Figure 2.10 – Cavitation number versus Kolmogorov length scale for constricting
square-edge, 45 degree angle, and fillet channels under the same 546 conditions with
the data grouped into cavitating and non-cavitating cases.
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Figure 2.11 – Cavitation number versus Kolmogorov length scale with threshold
bounds for dividing cavitating and non-cavitating cases.
Geometric Scalability of Diameter
For each of the previous models the minor diameter was held constant and the
major diameter was altered to accommodate the change in diameter ratio. Figure 2.12
shows the Kolmogorov length scale as a function of the Reynolds number for two
geometric configurations with the same diameter ratio of 0.5, but different major and
minor diameters. The channels have 2 and 4 mm minor diameters and 4 and 8 mm major
diameters respectfully. The resulting Kolmogorov length scales for each for the two
channels are different, but they both have the same slope. If the Kolmogorov length scale
is normalized by the minor diameter, the data collapse onto the same line as shown in
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Figure 2.13. Returning to plot the Cavitation number as a function of the Kolmogorov
length scale, Figure 2.14 demonstrates that regardless of diameter of the channels, the
threshold value previously defined holds true.
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Figure 2.12 – Kolmogorov length scale versus the Reynolds number for two
constricting square-edge channels with the same diameter ratios of 0.5, but different
minor and major diameters.
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Figure 2.13 – Normalized Kolmogorov length scale versus the Reynolds number for
two constricting square-edge channels with the same diameter ratios of 0.5, but
different minor and major diameters. The Kolmogorov length scale was normalized
by the minor diameter.
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Figure 2.14 – Cavitation number versus Kolmogorov length scale for two
constricting square-edge channels with the same diameter ratios of 0.5, but different
minor and major diameters. The threshold bounds previously defined are plotted to
determine if this trend holds true.
Recommendation for Pharmaceutical Industry
The application of these findings with respect to pharmaceutical manufacturing
demonstrates that cavitation is a problem in vial and syringe filling. However, when
developing new manufacturing systems steps can be taken to reduce the likelihood of
cavitation. The largest impact would be to add a fillet to every edge, but this is not always
feasible, so at minimum a tapered edge should utilized. This smoothing of the edge type
should be applied in piping systems, pumps, and valves. Next, much more thought should
be applied to reducing the amount of turbulence introduced into the system. This can be
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accomplished by reducing the Reynolds number of the flow. The Reynolds number can
be reduced by reducing the velocity and characteristic length of the system. Third, the
Cavitation number and Kolmogorov length scale should be calculated and applied to the
threshold boundary conditions to determine if the flow is in a cavitating or non-cavitating
region. If these steps are taken when designing new pharmaceutical manufacturing
systems the likelihood of cavitation can be greatly reduced. Proof of this is shown in
Figure 2.15 where a fillet edge is applied to the square-edge channel from Figure 2.3 that
had 101 cavitating cases and under the same conditions the fillet edge had no cavitating
cases.

Figure 2.15 – Diameter ratio versus the Reynolds Number with the data separated
by cavitating and non-cavitating conditions for the fillet channel. Overlaid on the
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data are general regions where vial filling, syringe filling, and syringe discharge
operations are likely to fall.
Conclusion
This research shows under current pharmaceutical manufacturing conditions,
especially in automated vial and syringe filling operations, cavitation is a real risk that
needs to be quantified and mitigated. The most universal method in determining the risk
of cavitation is by calculating the Cavitation number and Kolmogorov Length scale and
applying them to the threshold. Conservatively, if the Cavitation number is larger than
0.6 or the Kolmogorov Length scale is below 10μm then removing sharp edges by
rounding or reducing turbulence by reducing the mass flow rate or increasing the
viscosity is recommended. These conditions most likely occur at the outlet of pumps,
valves, and reductions of from areas (i.e. fill needles). Chapter 3 will examine if
cavitation is an issue in high energy impact cases where the fluid is not flowing
continuously though pipes, but instead is subject to a large deceleration rates.
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3. Chapter Three: Fluid Analysis of High Energy Cavitation Cases
Background
After a therapeutic protein is manufactured by medical companies, vials and
syringes are shipped and distributed for patient use. Transporting conditions can include
air travel, ground, and human handling. Each of these methods can impact vibrations and
drop impacts especially if an automated handling system is involved. Even if a package
containing a therapeutic protein is delivered incident free to a patient, the patient can
unpackage the preloaded vial or syringe and accidentally drop it. The research conducted
at the University of Colorado using a mechanical shock tower confirms when a vial of
therapeutic protein solution is involved in a drop scenario, protein degradation and
cavitation occurs [17]. Figure 3.1 shows still frame images, using a high speed camera, of
bubbles in a vial after an impact has occurred.

Figure 3.1 – High-speed frame shots of a vial impacting the surface of a mechanical
shock tower. Bubbles can clearly be seen which indicates that cavitation has
occurred [17].
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Energy in Drop
When a vial is dropped and impacts a surface, it experiences high g-forces as a
result of the rapid deceleration. These maximum g-forces can be effected by adding
packaging material to absorb the impact energy. The energy in the drop comes from the
potential energy and is a function of the drop height. The higher the drop height the
longer the vial has to accelerate resulting in a higher impact velocity. The rate of
deceleration is a function of the vial properties and surface material properties at the point
of the collision. For a 30 inch drop height with polyester urethane foam, the g-forces can
range greatly from 50 G when 2 inches of foam is used, 130 G when one inch of foam,
and higher g-forces when no foam is used [25]. Metal on metal contact is so violent it can
produce as much g-force as a pyrotechnic shock [25]. Although the duration of these high
g-forces are not long (1μsecond to 1 millisecond), it is known to produce pressure waves
that transfer through the vial and into the fluid. These shock or pressure waves emanate
from the face of the impact and move at the speed of sound in an outward direction. The
pressure waves have a high pressure region at the leading edge and on the back of the
wave there is a low pressure region. The question is whether this low pressure wave
produces a low enough pressure to cause the fluid to cavitate. The research by the
Randolph Group at the University of Colorado demonstrates an impact from a 10 inch
drop height causes cavitation and protein degradation [17].
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Energy Dissipation Techniques
Adding Packaging Material
Adding energy absorbing packaging material has been used for centuries to
transport goods from one point to another. These materials can range from simple paper
shavings to complex new foam materials. Therapeutic proteins are typically packaged
and sealed in 3 mL vials and placed in energy absorbing material prior to shipping and
distribution. When these vials are in packaging material the probability of cavitation is
reduced but not immune. For example, Amgen has monitored significant sub-visible
particle production in the vials shipped to themselves [17]. Upon removal from the
packaging material for storage in a refrigerator or for administering, the probability of a
vial drop has not diminished to zero and may be higher especially in cases of Rheumatoid
Arthritis patients.
Modeling impact dynamics is challenging because of the time scale over which
the shock forms and the velocity it travels (i.e. speed of sound). For that reason
experimental testing is typically performed to ensure a package design meets specified
standards [25]. If computational modeling is performed, the acceleration curve is usually
represented by a half sine wave or a two-term polynomial. Each of these general
equations have coefficients that will account for maximum acceleration and duration of
the total impacting time [26]. From the acceleration profile a velocity and position profile
can be created if boundary conditions are known. Additionally, it is assumed that when
modeling an impact the collision is elastic, therefore the object rebounds at the same
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velocity it impacted [26]. This is a very conservative assumption because it assumes a
higher g-force than actually occurs.
Container Shape
The shape of the container can affect the resulting pressure wave that emanates.
For example, if the bottom of the vial is flat a normal shock or pressure wave will form,
but if the vial has a curvature the pressure waves could be fanned out and dissipated or
focused and amplified. Take the case of a concave vial bottom shape, the pressure waves
are focused to the center of the vial and will collide and amplify. However, a convex
shape may generate weaker oblique shocks that travel away from the center of the vial.
Figure 3.2 shows a visual representation of how wave propagate of a concave and convex
surface.

Figure 3.2 – Wave propagation off of concave and convex surfaces [27].
Length Scale Fundamentals
Chapter 2 demonstrated that the Kolmogorov Length scale offers a good indicator
for the cavitation potential. The smaller the Kolmogorov Length scale, the more likely
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flow is to cavitate. The Kolmogorov Length scale is dominated by energy per mass and
the viscosity of the fluid.
Viscous Damping
Viscous fluid damping systems are widely used to dampen vibrating systems and
absorb shock. These are found in many applications from mountain bike shocks to fluid
built dampers. These systems utilize the viscous effects of fluids by retarding viscous
fluid flow through orifices. By changing the viscosity of the fluid in these systems, the
rate at which energy is absorbed by the fluid can be tuned.
Energy per Mass
When measuring the intensity of an event such as an impact the energy per mass
relation is generally used to relate one event to another. This can be seen when comparing
two car crashes with the same mass impacting the same solid object, but at different
speeds. The faster moving car will experience more damage because it contains more
energy. This energy is absorbed and dissipated through material deformation and
buckling. Although both cars have the same mass, they have different energy per mass
ratios. The same principles are true for a vial impacting a surface. By altering the energy
per mass ratio of the vial, the damage due to impact can be controlled.
Methods
Problem Description
Standard vial shipping containers were explored using 1/3 full, 3 mL vial modeled
with varying fluid properties, vial shape, and energy absorbing material properties. Figure
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3.3 shows the vial geometry commonly utilized by medical companies. This was the base
case used for comparison to altered conditions. The following fluid properties, vial shape,
and energy absorbing parameters altered were:
1. Packaging material
2. Contain shape
3. Viscous damping
4. Energy per mass ratio (i.e. density and fill height)
As previously discussed in Chapter 1, cavitation is a function of the localized low
pressure which is a function of fluid velocity, turbulence, and principle shear stress. The
results from this chapter will be quantified in local low pressure in the fluid system.
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Figure 3.3 – A geometric representation of an axisymmetric vial with an aqueous
protein solution. The unique base of the vial is the scanned contour of a standard 3
mL vials.
Fluid Model
To generate the Computational Fluid Dynamics (CFD) model ANSYS Fluent™
version 13.0.0 was again used in conjunction with Gambit® and Matlab. The vial was
modeled using a two dimensionl axisymmetric algorithm on a HP Z800 Workstation
using up to 7 processors. The models contained roughly 20,000 cells with a max
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skewness of 0.33. The model was run in a transient format with a time step of 5E-8
seconds and implemented with a pressure-based solver. Traditionally, a density-based
solver is utilized when a flow is supersonic and shockwaves are present, but in this
instance the pressure wave is moving through the fluid at the speed of sound and the fluid
is not at a high Mach number making this model acceptable to run in the pressure-based
solver. An explicit Volume of Fluid (VOF) solving scheme was implemented, which
utilized the momentum equation (Equation 11, Chapter 2), energy equation (Equation 12,
Chapter 2), continuity equation (Equation 14), and volume fraction equation (Equation
15).
1

∙
1

(14)

1
1

(15)

Where the q represents the number of phases, ṁqp is the mass transfer from phase
q to p and ṁpq is the mass transfer from p to q, αq is the volume fraction for phase q [23].
The standard k-ε turbulence model was implemented with standard wall functions. A user
defined function (UDF) was added to account for compressible properties not defined in
the standard Fluent database. This included the density of the fluid as a function of
pressure and the speed of sound in the fluid as a function of density. The fluid properties
and flow characteristics were altered for each model and were determined by the master
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Matlab code that was used to perturb the variable to explore the design space of
pharmaceutical relevance.
Packaging Material
To model different packaging materials, three different acceleration curves were
generated to represent a highly padded impact, slightly padded impact, and unpadded
impact of a vial striking a solid surface. The initial velocity of the vial at the moment
before impact is 4.15 m/s which represents the speed at which a vial would strike the
ground if it were dropped from an average height of an individual’s hand to the floor. The
details of the different conditions are presented in Table 3.1 and the profiles are plotted in
Figure 3.4. The duration on the impacts were determined by the amount of time need to
return the vial to its original velocity in the opposite direction.
Table 3.1 – Characteristics of 2”, 0.5”, and no foam padding impacts determined
from a two-term polynomial acceleration curve.
Impact description
2” Foam pad
0.5” Foam pad
Metal on metal impact

Initial impact
velocity (m/s)
4.15
4.15
4.15

Max g‐force
(g)
50
500
5000*

Time duration of
impact (ms)
25.00
2.50
0.25

*This impact may appear high, but using an accelerometer the Randolph group recorded
reading up to the limit of their accelerometer of 1000 G for metal on metal impacts.

50

Figure 3.4 – Plot of acceleration and velocity profiles for a 2” foam pad, 0.5” foam
pad, and no padding impacts.
Container Shape
To determine the effect of vial shape, specifically the impact surface shape, has
on the resulting pressure wave, different vial bottom curvatures were explored. It is not
logical to have a concave shape because the resulting pressure wave will propagate back
into the fluid. Therefore, a flat bottom and extremely convex shape will be modeled and
compared to the standard shape. For this sub-investigation the 500 g-force acceleration
impact was utilized because it is in the same range specified in standard package testing
[25]. Figure 3.5 shows the geometric representation of the different vial configurations.
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Figure 3.5 – A geometric representation of convex, standard, flat, and concave
shapes for the bottom of a 3 mL vial.
Viscous Damping
To determine the effect of the viscous damping in the vial, the viscosity will be
altered. Two additional cases were analyzed and compared with the standard 1 cP
viscosity of the base model. The two additional cases had a viscosity of 10 and 100 cP
which correspond to 10 and 25 mg/mL of IVIg proteins as measured by Giarratano. The
10 cP model represents a fluid with a high viscosity, but still flows easily. The 100 cP
viscosity represents a fluid that resembles a gel. For this investigation the slight padded
500 g-force acceleration impact was again utilized to conform to testing standards.
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Energy per Mass
To determine the effect of the energy per mass has on the vial impact, two
different approaches will be utilized. First, the fill height was changed from the normal
33% full, to 66%, and 100% to add mass to the system. Second, the height of the fluid
will remain constant, but the density of the fluid was changed to add mass to the system.
The density will be altered from a low protein level of 1000 kg/m3 to 1200 kg/m3 and
then 1500 kg/m3.
Results and Discussion
Packaging Material
Adding packing material to absorb impact energy and reduce the deceleration rate
can have a positive mitigating effect on cavitation in vials. Figure 3.6 shows the resulting
low pressure for each impact case and Table 3.2 reports the exact low pressure values.
Table 3.2 – Low pressure computational results from 2”, 0.5”, and no foam padding
impacts.
Low pressure (kPa)

2” Foam Padding
97.0

0.5” Foam Padding
60.8

No Padding
0.001

For a vial subjected to an impact with 2” of foam padding, the rebounding fluid
resulted in a low pressure cavity of 97.0 kPa, which is not capable of sustaining
cavitation, Figure 3.6. For a vial subjected to an impact with 0.5” of foam padding, the
rebounding fluid produced a low pressure cavity of 60.8 kPa which is not likely to result
in cavitation, based off of results from Chapter 2. For a vial subjected to an impact with
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no padding, the rebounding fluid produced a low pressure cavity of 1 Pa, therefore
cavitation will occur.

Figure 3.6 – Pressure contour for a 1/3 full vial impacting a surface under 3
different padding conditions. From left to right are the 2” foam pad, 0.5” foam pad
and the metal on metal impacts. Cavitation is not likely in the significantly padded
impact, possible in the slightly padded impact, and most defiantly in the non-padded
impact.
Adding energy absorbing material during shipping therapeutic proteins minimized
the consequence of protein degradation by cavitation in mishandled packages. However,
once a prefilled vial or syringe is out of the packaging and in the hands of a patient, it is
no longer protected and susceptible to being dropped. This is most problematic with the
elderly because they have trouble holding small objects and they have poor sensory and
reflex response. For this reason other energy dissipation strategies must be used in
conjunction with added packaging to eliminate cavitation due to an impact.
Container Shape
The effect of changing the bottom of the vial was examined and the low pressure
in each shaped vial was compared for the 0.5” foam impact. The low pressure did not
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change as a function of shape. The low pressure for each of the shapes was 60.8 kPa,
Table 3.3, which is not likely to result in cavitation based off of the results from Chapter
2.
Table 3.3 – Low pressure results for different bottom vial shapes under the 0.5”
foam padded impact.
Low pressure (kPa)

Standard
60.8

Flat Bottom
60.7

Convex
60.8

Viscous Damping
If the viscosity of the fluid is altered there is no difference in low pressure for
either of the 3 impact cases, Table 3.4. There are three potentially reasons the change in
viscosity had no effect on the damping in the fluid system. First, the time scale of
operation is too short to capture the nature of the bulk fluid viscosity. Second, the
rebounding of the vial is not being modeled and therefore, not capturing the effect of the
viscosity changes. Finally, the viscous damping of the fluid is not utilized because the
fluid is not flowing and a mass is not suspended in the fluid.
Table 3.4 – Low pressure results for different fluid viscosities under the 0.5” foam
impacting conditions.

Low pressure (kPa)

1
60.8

Viscosity (cP)
10
60.8
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100
60.7

Energy per Mass
Fill Height
To change the energy per mass of the system the volume of fluid inside the vial
can be altered. Changing this volume had no effect on the likelihood of cavitation until
the vial was completely filled with no gas at the top of the vial. Under this condition
regardless of the impact condition, cavitation occurred at the top of the vial. Additionally,
depending on the case, the fluid is likely to cavitate at a second location near the bottom
of the vial as previously seen. The cavitation at the top of the vial is due to the rapid
deceleration the vial when the fluid separates from the top of the vial.
Density
A second way to alter the energy per mass ratio is to change the density of the
fluid. Altering the density of the fluid results in changes to the low pressure values in the
fluid, Table 3.5. As the density increased, the mass in the system is increased, therefore
reducing the energy per mass relation and the likelihood of cavitation. The results of the
model, however, contradicted this theory showing an increase in the likelihood of
cavitation. This can be explained by taking a closer look at the energy per mass equation.
The primary source of energy in the vial immediately before impact is kinetic energy so
the energy per mass equation becomes Equation 16. When looking at this equation it can
be seen that the mass cancels and therefore the equation is independent of the mass. This
means the energy per mass is only a function of velocity, which leaves us with the
question why is there a difference in the low pressure when mass does not matter. The
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answer can be found in the setup of the computational model. The velocity and
acceleration curves for the vial are set for all the models regardless of the mass in the
system. By examining Newton’s Second Law, Equation 17, it is clear that if the
acceleration is fixed and the mass changes, the resulting force exerted on the fluid vial
system must increase. Therefore, increasing the density of the fluid or the volume in the
vial to increase the mass of the overall system will not decrease the likelihood of
cavitation if the acceleration and velocity curves for the model remain constant.
Table 3.5 – Low pressure results for different fluid densities under the 0.5” foam
impact conditions.

Low pressure (kPa)

1000
60.8

Density (kg/m^3)
1250
50.7

1
2

1500
40.7

2

(16)
(17)
Fluid Modeling Limitation
When modeling an impact such as a vial impacting a surface, many assumptions
are made to generalize the impact so the fluid model can be solved. In reality, we know
that the vial deforms and the resulting acceleration curve is not exactly a two-term
polynomial or half sine. By coupling CFD modeling with Finite Element Analysis (FEA)
a Fluid Solid Interaction (FSI) model can be implemented where the CFD and FEA
models share information to account for the fluid and solid interaction simultaneously.
FSI has the potential to add viscous damping to the system via vial deformation and wave
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propagation through the vial walls. Additionally, the resulting g-forces from the impact
will be solved for by the solid model, so no assumption would need to be made about the
max g-force and time duration of the impact. FSI modeling can also account for added
mass in the vial through density and fill height because the change in mass would change
the nature of the impacting vial. Chapter 4 will explore FSI modeling.
Conclusion
This research shows that by changing the packaging material the maximum gforce experienced by the vial can be reduced. This alone is not sufficient to stop all
cavitating cases because the vial is not always in the safety of packaging material. CFD
modeling shows that altering the density, viscosity, vial fill volume and vial bottom shape
are not sufficient methods for mitigating energy to reduce the likelihood of cavitation.
However, these changes may have an effect if FSI modeling is used to couple the fluid
and solid interactions. Chapter 4 will again examine if cavitation is an issue in extreme
impact cases, but it will utilize FSI modeling rather than just CFD modeling.
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4. Chapter Four: FSI Analysis of High Energy Cavitation Cases
Background
As previously discussed in Chapter 3, after therapeutic protein is manufactured it
is shipped and distributed for patient use. In the process of transporting therapeutic
proteins to the patient, the proteins can travel by air travel, ground, and human handling.
Packages containing these proteins can be dropped and vibrated while traveling via
planes and automobile, and impacted violently by the sorting equipment. Even if a
package containing a therapeutic protein is delivered incident-free to a patient, the patient
can unpackage the protein and accidentally drop it. The finds from the research
previously conducted in Chapter 3 and the research conducted at the University of
Colorado using a mechanical shock tower confirms that when a vial of therapeutic
protein solution is involved in a drop scenario, protein degradation and cavitation occurs
[17].
The research conducted in Chapter 3 involved Computation Fluid Dynamics
(CFD) modeling of a vial impacting a rigid surface. When modeling this impact the
acceleration curve was assumed to be a two-term polynomial with a maximum g-force
and duration of impact; It was held constant throughout all of the computational models.
In reality, the vial deforms and the resulting acceleration curve is not exactly a two-term
polynomial. By coupling CFD modeling with Finite Element Analysis (FEA), a Fluid
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Solid Interaction (FSI) model can be implemented where the fluid and solid models pass
information between models to account for the interactions between the fluid and solid.
When switching to a FSI model, the assumptions associated with the impact profile are
not made and instead the impact dynamics are solved through the FEA model. This
allows the impact dynamics to account for changes in mass and material properties of the
vial.
FSI Modeling
The ability to model the coupled relationship between solid material deformation
and elastic behavior on fluid flow behavior (and the reverse) is termed FSI modeling.
Solid material behavior techniques have largely grown from FEA, whereas the best fluid
dynamic simulation methods employ volume of fluid techniques. These are not terribly
compatible, and thus require interface information of pressure and geometry remodeling
to be transferred between the two algorithms. Therefore, this is a computationally
intensive activity, that until recently, was generally considered unfeasible for even
fundamental geometries. Published literature on FSI simulations, in fact, has only been
around since the late 90’s [28]. However, early results were plagued with inaccurate
simulation results due to artificial numerical instabilities. Only in the last ten years has
the mathematical limitations and ability to apply the technique to more complex
geometries become feasible. As a result only a handful of commercially available
software can perform FSI modeling, although this is technology is steadily increasing.
Common examples that require a fluid solid interaction to generate an accurate solution
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are the descent of a porous parachute, a piece of cloth falling through air, the flow in a
tube constricted with a flexible diaphragm, inflation of a balloon, flow through and
around a windsock, and even a patient-specific cerebral aneurysm [28–30].
The current work seeks to utilize FSI simulation in order to (1) accurately
replicate the impact dynamics as a function of vial properties, (2) understand the
deformation behavior of the vial and its consequences on cavitation within the fluid and
(3) explore a few of the variables from Chapter 3 to determine if including the vial
properties should be included in therapeutic formulation as implied by the FDA.
Methods
Problem Description
A half full 3 mL vial was modeled with a solid wall at the top of the vial. The
fluid geometry is represented in Figure 4.1 and the solid geometry is represented in
Figure 4.2. FSI modeling was implemented to capture the vial impacting a fixed surface
and the resulting action on the fluid in the vial and the deformation of the vial geometry.
The fluid viscosity and vial material properties were changed to explore their effects on
the fluid solid system.
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Figure 4.1 – A geometric representation of the cross sectional view of the 3D fluid
model.
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Figure 4.2 – Mesh of solid model evaluated by Abaqus. Left is an isometric view of
the entire vial and rigid impact surface. Right is a cross sectional view of the solid
vial mesh with the rigid impact surface.
Fluid Model
The CFD model was solved using ANSYS Fluent™ version 13.0.0 in conjunction
with Gambit® as the preprocessor. The vial was modeled using a 3D mesh contained
roughly 17,500,000 cells with a max skewness of 0.60. The model was run in a transient
format with a time step of 5E-8 seconds and implemented with a pressure-based solver.
Traditionally, a density-based solver is utilized when a flow is supersonic and
shockwaves are present, but in this instance, the pressure wave is moving though the fluid
at the speed of sound and the fluid is not at a high Mach number making this model
acceptable to run in the pressure-based solver. An explicit Volume of Fluid (VOF)
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solving scheme was implemented which utilized the momentum equation (Equation 11,
Chapter 2), energy equation (Equation 13, Chapter 2), continuity equation (Equation 14,
Chapter 3), and volume fraction equation (Equation 15, Chapter 3). The standard k-ε
turbulence model was implemented with standard wall functions. A User Defined
Function (UDF) was added to account for compressible properties not defined in the
standard Fluent database. This included the density of the fluid as a function of pressure
and the speed of sound in the fluid as a function of density. No phase change was
specified, so the low pressure in the protein solutions may drop below zero.
Solid Model
The FEA models were solved using Abaqus 6.11 in conjunction with HyperMesh
10.1 as the preprocessor. A mesh was created to represent the vial consisting of
approximately 73,000 C3D8 hexaheadral elements with a minimum Jacobian of 0.73.
Glass material properties were assigned to the elements of the vial defined in Table 4.1.
An element set was created to represent a solid surface for the vial to impact a rigid
surface, containing 225 S4R shell elements with a minimum Jacobian of 1. This mesh
was fixed in 6 degrees of freedom and defined as a rigid body. General contact between
the two mesh surfaces was specified. The loading condition for the vial was an initial
downward velocity of 4.165 m/s. A dynamic explicit solving scheme was used to solve
the solid model.
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Fluid Solid Interaction Model
The FSI software used to couple the FEA and CFD models together was MpCCI
4.1.1 (Mesh-based parallel Code Coupling Interface). The computational models were
solved on a HP Z800 Workstation with 6 processors dedicated to the CFD Fluent model
and one dedicated to the FEA Abaqus model and one for the MpCCI interfacing
software. The fluid and solid interface surfaces were linked. The nodal positions for the
solid model were used to change the shape of the fluid volume and the pressure in the
fluid model was used as an input into the walls of the solid model. The weak coupling
algorithm was utilized for interpreting the changes in the nodal values starting with the
solid model. Figure 4.3 shows the flow of data through one time step. Because the solid
model is initializing the coupled system, the FEA model started the first time step and
then passed information to Fluent. If the instability of the FSI model is below one, it is
likely to be unstable. The instability is calculated using Equation 18, where ρs is the
density of the solid, ρf is the density of the fluid, hs is the thickness of the solid, R is the
radius of the fluid passageway, and L is the length of the fluid passageway. Under the
conditions of this model, the stability of the system was calculated to a minimum of 3.6
[29,32]. Therefore, the model is considered a stable model.
2

2

2
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1

(18)

Figure 4.3 – Flow chart depicting the flow of information passed between softwares
to complete a time step [31].
Evaluated Models
Three FSI models under different conditions were investigated with the intent of
determining (1) how the impact deceleration is altered compared to those assumed in
Chapter 3, (2) how the material properties and dynamics of the vial alter cavitation, and
(3) if the viscosity still plays an insignificant role in mitigating cavitation under these
mechanical shock conditions, in contrast to Chapter 2. All models are run from a similar
drop height, fluid density, fill volume and vial bottom curvature. However, the vial
material is altered from glass to plastic, and the solution viscosity is raised and compared
to a base case. The specific conditions of the three models are outlined in Table 4.1. The
high viscosity case will show the potential for changes in the fluid model to alter the
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likelihood of cavitation, and the change in the vial material will show potential for
changes in the solid deformation to alter the likelihood of cavitation.
Table 4.1 – Values used by the fluid and solid models for the 3 different conditions
evaluated.

Fluid
Properties

Solid
Properties

Base conditions

High viscosity

Plastic vial

4.165

4.165

4.165

1

100

1

Material name

Glass

Glass

Plastic

3

Density (kg/m )

2600

2600

1200

Young's Modulus (Gpa)

70.0

70.0

2.3

Poisons ratio

0.22

0.22

0.22

Impact velocity (m/s)
Viscosity (cP)

Results and Discussion
CFD Modeling and FSI Modeling Comparison
The results from the FSI modeling are different from the results the CFD model
from Chapter 3. The major difference is the assumptions about the impact dynamics. In
the Chapter 3 analysis, the CFD models had a fixed velocity and acceleration curves.
However, in the FSI model the velocity and acceleration curves are a function of the solid
model.
Pressure Wave Propagation
The results of transient coupling of the fluid and solid model resulted in a pressure
wave passing though the fluid at the speed of sound. Images of the propagating wave can
be seen in Figure 4.4 with a pressure wave propagating through the fluid and several low
pressure regions behind the pressure wave. Figure 4.5 shows the shock wave at three
different time intervals. The distance between the waves was measured and the elapsed
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time between the images results in a wave speed of approximately 1503 m/s. The speed
of sound in a liquid is defined by Equation 19, where c is the speed of sound, Ev is the
isentropic bulk modulus. Comparing the calculated speed of sound, 1497 m/s, with the
measured speed from the images, 1503 m/s, there was less than 0.4% error. The FSI
model was the first model that captured the pressure wave detaching from the vial and
traveled through the fluid. The fact that the wave moves at the speed of sound is a good
check to ensure the fluid system is producing physical results, but it is insufficient to
validate the system.

(19)

Figure 4.4 – Frame shots of the pressure contour for the transient FSI model. The
absolute pressure contour is plotted for a series of images as the model progresses in
time. A pressure wave is seen passing through the fluid and several low pressure
regions are present behind the propagating wave.
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Figure 4.5 – Pressure wave propagating though the liquid solution at the speed of
sound. The speed was determined by the distance of the leading edge of the wave
and the time difference between images.
Bubble Location
As the low pressure wave passes through the vial and reaches about 10 mm off of
the base (about 4E-6 seconds after impact), the low pressure region remains attached at
the center bottom surface of the vial. Higher pressure regions form in the corner,
indicative a constructive pressure wave reflecting from the side walls. A small pressure
cell is located in the center of vial. This eventually divides the low pressure areas into
two locations, which are similar to the number and locations of the bubbles observed in
experimental images collected by the Randolph Group. Figure 4.6 compares the low
pressure regions in the CFD model and the bubble locations in the images. This is not a
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quantitative validation of the model, rather another qualitative identification of
similarities, which were not obtained in the fluid-only simulations of Chapter 3. To
gather quantitative validation, the FSI model would need to include phase change
behavior so that the lifetime of the bubble and diameter could be tracked as a function of
time. The addition of phase change was beyond the scope of the current investigation.

Figure 4.6 – Comparison of the low pressure regions in the CFD model and the
bubble locations in the images from the Randolph Group [17].
Viscous Effect
The result of changing the viscosity of the fluid increased the lowest overall
pressure during the simulation, and it suggested that it may have accelerated cavitation.
Figure 4.7 shows the base case compared to the high viscosity case. The lower the
pressure in the wave, the more intensity it carries. When the viscosity is increased from 1
cP to 100 cP, the pressure in the wave decreases, which indicates a stronger pressure
wave passing through the fluid. Due to only analyzing two viscosity conditions, it is
difficult to hypothesize why an increase in viscosity results in a lower pressure and more
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intense pressure wave. However, the change in low pressure and pressure wave intensity
does show that changes in the fluid properties can affect the probability of cavitation, in
fact the results of previous research suggest that increasing viscosity can have a
beneficial or harmful effect on cavitation depending on the range [5]. Looking back on
the results from Chapter 3 and the CFD modeling, a change in viscosity had no effect on
the low pressure or likelihood of cavitation. This difference in the results indicates a
deeper study is needed to fully understand the connection between viscosity and
cavitation in an extreme impact case.
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Figure 4.7 – Low pressure versus time in the normal viscosity glass case, high
viscosity glass case, and normal viscosity plastic vial cases. No phase change is
present, which results in a pressure value of below 0 atmospheres in areas where
phase change would occur.
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Vial Material Effect
Altering the material properties of the vial resulted in a large increase in the
lowest pressure observed indicating cavitation was less strong. The decrease was
insufficient to indicate a complete shutdown of the phase change by pressure boiling.
Figure 4.7 shows the glass vial case compared to the plastic vial as a function of time.
When the material in the vial was changed from glass to plastic, the pressure in the wave
increased indicating a weaker pressure wave passing through the fluid. A weaker pressure
wave was to be expected because plastic is likely to absorb more energy compared to
glass due to its smaller Young’s Modulus and ability to deform. This change in the
magnitude of the pressure is significant and indicates a deeper study could potentially
lead to insightful results.
Conclusion
The result of the FSI models indicate there is a connection between the fluid and
solid model and shows that changing the properties in the solid model will change the
result in the fluid model and vice versa. Although, this study does produce expected and
physical results, a validation of the model should be completed. The FSI modeling also
indicates that an impact should not simply be modeled as a two-term polynomial, but
rather be a function of the solid model. This work supports the FDA’s notion that the vial
is part of the formulation of the therapeutic protein system and should be appropriately
designed to accommodate the therapeutic protein. This, however, is not the current
practice of the BioPharm industry, and thus has the potential for significant impact to
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industrial practices. Furthermore, additional research is needed to determine the
significance of various fluid properties and vial parameters with respect to the likelihood
of cavitation under high energy impacts.

73

5. Chapter Five: Conclusion
Constriction Channel Investigation
A computational fluid dynamics investigation of constricting channels was
conducted to assess the risk of cavitation under typical pharmaceutical processing and
delivery conditions. An evaluation of the entire automated pharmaceutical filling
machine space was evaluated for more than 546 geometric, operating and fluid property
conditions. It was determined that cavitation is highly probable in vial and syringe filling
operations. The entire data set was utilized to develop a simple method to set a threshold
for cavitation that process engineers could utilize to redesign or mitigate cavitating
systems. We determined that the Cavitation number and Kolmogorov Length scale
provide a robust method to establish this threshold criterion. The threshold for noncavitating bonds can be found by the following:
Non-cavitating if:
η < 8 μm

while

0.1

η > 8 μm

while

0.6

0.8617

Based on the results of this investigation, systems that are creating sub-visible
protein particles should (1) fillet or round all contraction edges, (2) reduce the amount of
energy per unit mass placed into the system or raise the fluid viscosity to increase the
Kolmogorov Length scale, and (3) reduce the amount of turbulence in the fluid.
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To complete this investigation an experimental study should be carried out to
verify cavitation is mitigated at the threshold and to demonstrate that this leads to a
reduction in the number of sub-visible protein aggregate particles in solution. The
threshold validation should include a wide range of constriction flow speeds and
constriction edge types to ensure this threshold is universally true.
High Energy Cavitation Cases
A fluid only computational model of a vial drop scenario was simulated to
understand if cavitation could be responsible for sub-visible protein particle formation
under these conditions. This model utilized a two-term polynomial fit of the acceleration
curve without phase change to observe the potential of cavitation after vial impact.
Simulations recorded unphysical negative pressure regions on the bottom surface of the
vial after impact which indicates phase change would have occurred. These negative
pressure regions would be corrected if a phase change model was utilized. An
investigation of the solution viscosity, surface curvature, and energy absorbing material
revealed that the effect of the viscosity and surface curvature on the low pressure regions
were minimal, while the energy absorbing material was sufficient to shutdown cavitation.
Studies understanding the influence of fluid density or mass on the behavior of the
system indicated limitations and possible failures of the modeling approach.
A Fluid Solid Interaction (FSI) model was developed to couple the fluid and
solid system, resulting in a more accurate and robust impact compared to the fixed
polynomial. Only a preliminary study was conducted to understand the influence of fluid
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and material properties on cavitation. The influence of solution viscosity had only a
minor effect; this may be result of the time scale over which the forces and accelerations
operate on do not allow sufficient fluid flow reaction time. The influence of vial
properties was pronounced, indicating the vial properties (shape and elasticity) could be
sufficient to mitigate cavitation in vial drop scenarios. This result argues that the vial
should be included in the therapeutic formulation development.
Future work is needed on the computational and experimental side to validate the
FSI model by adding phase change so that bubble size, bubble lifetime and interface
jetting can be tracked in relation to experimental results. Additionally, an investigation,
similar in scope to the one in Chapter 3, should be performed which includes altering
fluid properties, material properties of the vial, vial interior and exterior shape, and
impact absorbing material between the vial and the rigid surface.
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